Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Lung Cancers: Molecular Characterization, Clonal Heterogeneity and Evolution, and Cancer Stem Cells
Ugo Testa, Germana Castelli, Elvira Pelosi
Cancers (2018) Vol. 10, Iss. 8, pp. 248-248
Open Access | Times Cited: 324

Showing 26-50 of 324 citing articles:

Olaparib as maintenance treatment in patients with chemosensitive small cell lung cancer (STOMP): A randomised, double-blind, placebo-controlled phase II trial
Penella J. Woll, Piers Gaunt, Sarah Danson, et al.
Lung Cancer (2022) Vol. 171, pp. 26-33
Open Access | Times Cited: 33
Assessing dynamic metabolic heterogeneity in non-small cell lung cancer patients via ultra-high sensitivity total-body [18F]FDG PET/CT imaging: quantitative analysis of [18F]FDG uptake in primary tumors and metastatic lymph nodes
Daquan Wang, Xu Zhang, Hui Liu, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2022) Vol. 49, Iss. 13, pp. 4692-4704
Closed Access | Times Cited: 29
Delta-radiomics in cancer immunotherapy response prediction: A systematic review
Engy Abbas, Salvatore Claudio Fanni, Claudio Bandini, et al.
European Journal of Radiology Open (2023) Vol. 11, pp. 100511-100511
Open Access | Times Cited: 17
Dihydroartemisinin, a potential PTGS1 inhibitor, potentiated cisplatin-induced cell death in non-small cell lung cancer through activating ROS-mediated multiple signaling pathways
Lianli Ni, Xinping Zhu, Qi Zhao, et al.
Neoplasia (2024) Vol. 51, pp. 100991-100991
Open Access | Times Cited: 6
MicroRNA‐331‐3p inhibits epithelial‐mesenchymal transition by targeting ErbB2 and VAV2 through the Rac1/PAK1/β‐catenin axis in non‐small‐cell lung cancer
Xizhe Li, Jiali Zhu, Yuanqi Liu, et al.
Cancer Science (2019) Vol. 110, Iss. 6, pp. 1883-1896
Open Access | Times Cited: 52
Organoid models in lung regeneration and cancer
Jianhai Wang, Xianglu Li, Huaiyong Chen
Cancer Letters (2020) Vol. 475, pp. 129-135
Closed Access | Times Cited: 49
Real-world treatment and survival of patients with advanced non-small cell lung Cancer: a German retrospective data analysis
F. Hardtstock, David T. Myers, Tracy Li, et al.
BMC Cancer (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 46
Recent updates on the resistance mechanisms to epidermal growth factor receptor tyrosine kinase inhibitors and resistance reversion strategies in lung cancer
Surya Kant Tripathi, Kamal Pandey, Kannan R. R. Rengasamy, et al.
Medicinal Research Reviews (2020) Vol. 40, Iss. 6, pp. 2132-2176
Closed Access | Times Cited: 42
ESCO2 promotes lung adenocarcinoma progression by regulating hnRNPA1 acetylation
Hui-er Zhu, Tao Li, Shengnan Shi, et al.
Journal of Experimental & Clinical Cancer Research (2021) Vol. 40, Iss. 1
Open Access | Times Cited: 36
LncRNA ADAMTS9-AS2 is a Prognostic Biomarker and Correlated with Immune Infiltrates in Lung Adenocarcinoma
Zhichao Lin, Wenhai Huang, Yongsheng Yi, et al.
International Journal of General Medicine (2021) Vol. Volume 14, pp. 8541-8555
Open Access | Times Cited: 35
Cathepsin C inhibition as a potential treatment strategy in cancer
Brice Korkmaz, Anne‐Sophie Lamort, Roxane Domain, et al.
Biochemical Pharmacology (2021) Vol. 194, pp. 114803-114803
Open Access | Times Cited: 34
Dipeptidyl peptidase 1 inhibition as a potential therapeutic approach in neutrophil-mediated inflammatory disease
James D. Chalmers, Ralph Kettritz, Brice Korkmaz
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 16
Dissecting the single-cell transcriptome network of macrophage and identifies a signature to predict prognosis in lung adenocarcinoma
Zhengyang Hu, Xing Jin, Weifeng Hong, et al.
Cellular Oncology (2023) Vol. 46, Iss. 5, pp. 1351-1368
Open Access | Times Cited: 13
Prognostic significance of TOP2A in non-small cell lung cancer revealed by bioinformatic analysis
Wenxia Ma, Bin Wang, Yaping Zhang, et al.
Cancer Cell International (2019) Vol. 19, Iss. 1
Open Access | Times Cited: 40
LncRNA NNT‐AS1 promotes non‐small cell lung cancer progression through regulating miR‐22‐3p/YAP1 axis
Wenlong He, Yeying Zhang, Shulan Xia
Thoracic Cancer (2020) Vol. 11, Iss. 3, pp. 549-560
Open Access | Times Cited: 39
In Vitro and In Silico Evaluation of Anticancer Activity of New Indole-Based 1,3,4-Oxadiazoles as EGFR and COX-2 Inhibitors
Belgin Sever, Mehlika Dilek Altıntop, Ahmet Özdemır, et al.
Molecules (2020) Vol. 25, Iss. 21, pp. 5190-5190
Open Access | Times Cited: 38
PNO1, which is negatively regulated by miR-340-5p, promotes lung adenocarcinoma progression through Notch signaling pathway
Dongming Liu, Lin Li, Yajie Wang, et al.
Oncogenesis (2020) Vol. 9, Iss. 5
Open Access | Times Cited: 37
Elevation of FGD5-AS1 contributes to cell progression by improving cisplatin resistance against non-small cell lung cancer cells through regulating miR-140-5p/WEE1 axis
Jun Fu, Hangmei Cai, Yan Wu, et al.
Gene (2020) Vol. 755, pp. 144886-144886
Closed Access | Times Cited: 35
FAM83A Is a Prognosis Signature and Potential Oncogene of Lung Adenocarcinoma
Jing Yu, Min Hou, Tianxian Pei
DNA and Cell Biology (2020) Vol. 39, Iss. 5, pp. 890-899
Closed Access | Times Cited: 34
Lung cancer in women in 21th century
Joanna Domagała‐Kulawik, Anna Trojnar
Journal of Thoracic Disease (2020) Vol. 12, Iss. 8, pp. 4398-4410
Open Access | Times Cited: 33
Prognostic Significance of Stromal Periostin Expression in Non-Small Cell Lung Cancer
Katarzyna Ratajczak‐Wielgomas, Alicja Kmiecik, Jędrzej Grzegrzółka, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 19, pp. 7025-7025
Open Access | Times Cited: 33
Curcumin and cancer biology: Focusing regulatory effects in different signalling pathways
Muskan Bhatia, Mihir Bhalerao, Natália Martins, et al.
Phytotherapy Research (2021) Vol. 35, Iss. 9, pp. 4913-4929
Closed Access | Times Cited: 32
KRAS G12C Mutation Is Associated with Increased Risk of Recurrence in Surgically Resected Lung Adenocarcinoma
Gregory D. Jones, Raul Caso, Kay See Tan, et al.
Clinical Cancer Research (2021) Vol. 27, Iss. 9, pp. 2604-2612
Open Access | Times Cited: 30
NCAPG promotes the progression of lung adenocarcinoma via the TGF-β signaling pathway
Yun Wu, Ying Lin, Junfan Pan, et al.
Cancer Cell International (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 30
Regulation of cell growth, survival and migration by ceramide 1-phosphate - implications in lung cancer progression and inflammation
Ana Gómez-Larrauri, Alberto Ouro, Miguel Trueba, et al.
Cellular Signalling (2021) Vol. 83, pp. 109980-109980
Open Access | Times Cited: 29

Scroll to top